NCT04610970 2021-08-18A Study of TQ-B3525 in Subjects With Relapse/Refractory Diffuse Large B-cell Lymphoma （DLBCL）Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 2 Unknown93 enrolled